RE:RE:RE:RE:RE:RE:distribution deals next week?Royalty rate is not discussed pre or after generic launch. This means it is exactly the same why would it be different? There is zero reason! If generic takes a big bite both parties suffer period. The deal with Sun expires next year they can renegotiate with Cipher at that time. If not cipher can sell the rights to the highest bidder or make another deal with someone who might do a better job than Sun or do what there doing in Canada and just enjoy the branding which alone would bring in more than Sun is paying them. Like I said before Activis appears that they are NOT going to launch a generic which is worth millions to Cipher and Sun. It maybe Covid delaying it or the cost to develop was too high to justify. Generics always move in when a drug has strong market share luckily Absorica has steadily lost market share since 2013 when Activis wanted to launch its generic version.